Trials / Completed
CompletedNCT04516928
Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 392 (actual)
- Sponsor
- Direction Centrale du Service de Santé des Armées · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Emerging in China in December 2019, Covid-19, whose pathogen is SARS-Cov-2, was declared a global pandemic in March 2020. The clinical presentation is highly variable, ranging from asymptomatic forms to acute respiratory distress and even death. Transmission is by droplet route, with an R0 of approximately 3. Rapidly, population protection measures were put in place by governments, including the confinement of all persons whose functions were not considered essential and the closure of educational institutions. Health care institutions are places at risk of Covid-19 transmission and hospital staff are particularly exposed, either through direct contact with patients, contact with exposed persons or through the environment. In order to protect personnel, hygiene measures were immediately recalled and reinforced. During the period of containment, the majority of students from the Lyon-Bron Military Medical Schools were sent as reinforcement in Army Training Hospitals and in the Military Reanimation Unit (Mulhouse). Some students developed symptomatic forms of SARS-Cov-2 infection, documented by positive PCR, during Operation Resilience or on their return from the mission. The Lyon-Bron Military Medical Schools staff, exposed both to the initial phase of the epidemic and to national protection measures, represent an extremely interesting population for understanding the epidemiological dynamics of the virus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Anti-SARS-CoV2 Serology | The anti-SARS-CoV2 serological status will be measured on a blood sample collected at Day 0. |
| OTHER | Questionnaire | A questionnaire on socio-demographical status, health status and lifestyle habits during the pandemic will be filled by the participants at Day 0. |
Timeline
- Start date
- 2020-09-21
- Primary completion
- 2020-09-25
- Completion
- 2020-09-25
- First posted
- 2020-08-18
- Last updated
- 2021-03-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04516928. Inclusion in this directory is not an endorsement.